The cost of a prescription is separate from spending on hospital visits and other care. In a study of medical spending among people who stayed on semaglutide, those treated had lower average medical costs than matched controls. That result does not tell us whether the price of the medication was recovered or whether similar savings would apply to people who stopped early [2].
What did the tirzepatide study count?
Researchers matched 15,843 adults starting tirzepatide to 15,843 adults who received no incretin therapy. Participants were older than 55, had obesity or overweight with a weight-related condition, and did not have type 2 diabetes [1].
Excluding tirzepatide, the change in monthly costs at months 6–12 was $145 lower per person than in the comparison group (95% CI $25 to $266 lower). At months 12–18, it was $319 lower ($94 to $544 lower). These are differences in cost changes, and the estimates depended on how the researchers handled follow-up. Inpatient and emergency department visits were less frequent in the tirzepatide group at months 12–18. Eli Lilly funded the analysis[1].
What did the semaglutide study find?
In SHINE-ASCVD, 770 adults with overweight or obesity and atherosclerotic cardiovascular disease who stayed on semaglutide 2.4 mg were compared with 3,080 matched controls. Average annual medical spending was $4,639 lower per person in the semaglutide group, with much of the difference coming from inpatient costs. The comparison counted medical expenses, and the claims study could not establish whether semaglutide caused the difference [2].
Could your own spending go down?
A study of out-of-pocket spending after semaglutide or bariatric surgery illustrates why the answer can differ for patients and insurers. Over three years, adjusted out-of-pocket spending among people with type 2 diabetes and BMI of at least 35 was $7,752 for semaglutide, $5,980 for sleeve gastrectomy and $6,591 for gastric bypass. Total spending did not show a statistically clear difference across the three groups[3].
These studies cannot predict what you will pay. Your own costs depend on prescription coverage and the costs your plan assigns to other care.